Ofloxacin

Specifications

82419-36-1CAS Number

617-457-2EC Number

7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acidIUPAC Name

C18H20FN3O4Chemical Formula

361.4 g/molMolecular Weight

ofloxacin; 82419-36-1; Floxin; Ofloxacine; Tarivid; Ocuflox; Ofloxacino; Visiren; Ofloxacinum; DL-8280; Ofloxacina; Exocin; Hoe-280; Floxin otic; Ofloxacin Otic; OFLX; HOE 280; FLOXIN IN DEXTROSE 5%; DL 8280; DTXSID3041085; A4P49JAZ9H; NSC-727071; NSC-758178; CHEBI:7731; 7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid; FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER; J01MA01; DTXCID1021085; NSC727071; 8-Fluoro-3-methyl-9-(4-methyl-piperazin-1-yl)-6-oxo-2,3-dihydro-6H-1-oxa-3a-aza-phenalene-5-carboxylic acid; 9-FLUORO-2,3-DIHYDRO-3-METHYL-10-(4-METHYL-1-PIPERAZINYL)-7-OXO-7H-PYRIDO(1,2,3-DE)(1,4)BENZOXAZINE-6-CARBOXYLIC ACID, DL-; Ofloxaxin; Tarivid i.v.; 7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo(7.3.1.05,13)trideca-5(13),6,8,11-tetraene-11-carboxylic acid; Ofloxacin Ophthalmic; Olfoxacin Otic Soln; Ofloxacin Ophth Soln; Tarivid 400; Ofloxacin Otic solution; RefChem:6082; 7-fluoro-2-methyl-6-(4-methylpiperazin-4-ium-1-yl)-10-oxo-4-oxa-1-azatricyclo(7.3.1.05,13)trideca-5(13),6,8,11-tetraene-11-carboxylate; S01AE01; S02AA16; Ru43280; ORF28489; ORF 28489; Ru 43280; DR 3355; Ofloxacin Ophthalmic Solution USP, 0.3%; (+-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7--oxo-7H-pyrido(1,2,3-de)--1,4-benzoxazine-6-carboxylic acid; (3RS)-9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-pyrido(1,2,3-de)(1,4)benzoxazine-6-carboxylic acid; DL8280; Hoe280; 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid; 83380-47-6; MFCD00226105; Oxaldin; 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid; Oflocet; CHEMBL4; MLS000028749; 9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid; s1940; Ofloxacina [DCIT]; Ofloxacine [French]; Ofloxacinum [Latin]; Exocine; SMR000058192; Zanocin; Ofloxacino [Spanish]; 9-Fluoro-3,7-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic Acid; OFX; F0472-0226; Flobacin; Floxil; PT 01; ORF 18489; 7-Fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5,7,9(13),11-tetraene-11-carboxylic acid; Floxin (TN); CCRIS 5233; (+/-)-Floxin; SR-01000076050; UNII-A4P49JAZ9H; BRN 3657947; DL-ofloxacin; Mefoxacin;; Flobacin;; Ocuflox;; Oflocet;; Oflocin;; Oxaldin;; Exocin;; Ofloxacin CRS; HSDB 8030; NCGC00016948-01; (-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1;(-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1; CAS-82419-36-1; Exocin (eye drops); Ofloxacin (Standard); Ofloxacin [USAN:USP:INN:BAN:JAN]; (+-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid; WP-0405; Spectrum_001186; OFLOXACIN [INN]; OFLOXACIN [JAN]; OFLOXACIN [MI]; OFLOXACIN [USAN]; Opera_ID_1114; Prestwick0_000237; Prestwick1_000237; Prestwick2_000237; Prestwick3_000237; Spectrum2_001464; Spectrum3_001499; Spectrum4_000324; Spectrum5_001063; OFLOXACIN [VANDF]; Epitope ID:116889; OFLOXACIN [MART.]; O 8757; OFLOXACIN [USP-RS]; OFLOXACIN [WHO-DD]; Lopac0_000904; Oprea1_242882; SCHEMBL24373; BSPBio_000313; BSPBio_003117; KBioGR_000667; KBioSS_001666; fluoro-methyl-(4-methylpiperazin-1-yl)-oxo-[?]carboxylic acid; MLS001074203; MLS006011774; orb320681; XED; DivK1c_000721; SPECTRUM1502044; SPBio_001387; SPBio_002234; Ofloxacin (JP18/USP/INN); BPBio1_000345; orb1223933; orb1225676; orb1310184; orb3139966; OFLOXACIN [ORANGE BOOK]; OFLOXACIN [EP MONOGRAPH]; SCHEMBL14163982; GTPL10918; HMS502E03; HY-B0125R; KBio1_000721; KBio2_001666; KBio2_004234; KBio2_006802; KBio3_002617; MSK5740; OFLOXACIN [USP MONOGRAPH]; CHEBI:194135; NINDS_000721; AO128; HMS1568P15; HMS1921H12; HMS2090F07; HMS2092B10; HMS2095P15; HMS2235C05; HMS3259G07; HMS3262F10; HMS3369B01; HMS3393K06; HMS3604B17; HMS3712P15; HMS5080D07; HMS5083P19; HMS5087O15; Pharmakon1600-01502044; SMSSF-0055683; HY-B0125; RKL10083; UYB17021; Ofloxacin, fluoroquinolone antibiotic; Tox21_110703; Tox21_500904; BBL005605; BDBM50045004; CCG-39210; EBC-08557; MSK5740-100M; NSC758178; s1463; STK256723; AKOS001033517; AKOS016042783; Ofloxacine; DL-8280; HOE-280; Tox21_110703_1; AC-7616; AO26535; CS-1891; DB01165; KS-5011; LP00904; NC00466; NSC 727071; NSC 758178; Ofloxacin 100 |Ig/mL in Acetonitrile; SDCCGSBI-0050879.P004; IDI1_000721; NCGC00015772-02; NCGC00015772-03; NCGC00015772-04; NCGC00015772-05; NCGC00015772-06; NCGC00015772-07; NCGC00015772-08; NCGC00015772-09; NCGC00015772-10; NCGC00015772-12; NCGC00015772-13; NCGC00015772-22; NCGC00094219-01; NCGC00094219-02; NCGC00094219-03; NCGC00094219-04; NCGC00094219-05; NCGC00094219-06; NCGC00178284-01; NCGC00178284-02; NCGC00261589-01; Ofloxacin 100 microg/mL in Acetonitrile; (+-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)(1,4)benzoxazin-6-carbonsaeure; (+/-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid; 7H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 2,3-dihydro-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (+-)-; 7H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (+-)-; ST073364; SY052697; Ofloxacin Solution in Methanol, 100ug/mL; SBI-0050879.P003; DB-056608; AB00513820; EU-0100904; NS00098749; O0403; O2144; EN300-06482; Ofloxacin, VETRANAL(TM), analytical standard; VU0243192-7; C07321; D00453; AB00052263-12; AB00052263-13; AB00052263_14; AB00052263_15; F858780; Q411447; SR-01000076050-1; SR-01000076050-4; SR-01000076050-7; BRD-A24228527-001-05-9; BRD-A24228527-001-19-0; BRD-A24228527-001-31-5; BRD-A24228527-213-01-9; SR-01000076050-16; Z56761309; F0020-0095; Ofloxacin, European Pharmacopoeia (EP) Reference Standard; Ofloxacin, United States Pharmacopeia (USP) Reference Standard; (+/-)-9-Fluoro-2,2,3-de)-1,4-benzoxazine-6-carboxylic acid; Ofloxacin, Pharmaceutical Secondary Standard; Certified Reference Material; (RS)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid; 7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.0,5,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid; 7H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-; 7H-PYRIDO(1,2,3-DE)-1,4-BENZOXAZINE-6-CARBOXYLIC ACID, 9-FLUORO-2,3-DIHYDRO-3-METHYL-10-(4-METHYL-1-PIPERAZINYL)-7-OXO-, (+/-)-; 8-fluoro-3-methyl-9-(4-methyl-1-piperazinyl)-6-oxo-1-oxa-3a-aza-2,3-dihydro-6H-phenalene-5-carboxylic acid; 9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido [1,2,3-de]-1,4-Benzoxazin-6-carboxylic Acid; 9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid; 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylicacid; 9-fluoro-3-methyl-10-(4-methylpiperazino)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acidSynonyms